Advantages

CD19 CAR-T lentiviral packaging is performed using Jiangsu Hillgene’s VSV-G envelope four-plasmid system. VSV-G pseudotyped LVVs adhered to and entered the cell by recognizing the low-density lipoprotein receptor (LDL-R) on the cell surface. The prevalence of LDL-R on the cell membrane enabled VSV-G to allow LVVs to enter a variety of cells. At present, VSV-G pseudotyped LVVs are widely used in the transduction of human and other mammalian cells, and CD19 CAR-T can efficiently and specifically kill CD19-positive cells, which provides a very good research tool for preclinical studies of gene/cell therapy and is of great significance for promoting the development of gene/cell therapy.

CD19 CAR-T Vector Design

CD19 CAR-T Lentivirus Preparation Process

CD19 CAR-T Lentivirus Quality Standard

*Specific products to be sold are determined according to the actual batch.

Data

1. CD19 CAR-T Cell Preparation Process

2. CAR-T Detection Data

3. CAR-T Cell Quality Standard

Product Order Information